Facebook Instagram X-twitter Linkedin

DSIP (5mg)

Table of Contents

  • Quickstart Highlights

DSIP (5mg) protocols focus on Delta Sleep-Inducing Peptide, a naturally occurring neuromodulatory peptide studied for its potential role in regulating sleep cycles, stress response, and neuroendocrine balance. DSIP may support deeper sleep quality, improved recovery, and relaxation by influencing central nervous system signaling. This guide outlines a subcutaneous administration approach optimized for the 5 mg vial format.

  • Reconstitute: Add 1.0 mL bacteriostatic water → 5 mg/mL concentration
  • Typical range: 100–300 mcg per dose (subcutaneous or intranasal in research settings)
  • Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg (0.05 mg) on a U-100 insulin syringe
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks
  • Protocol Overview

Concise summary of the regimen.

  • Goal: Support sleep quality, relaxation, and stress regulation
  • Schedule: Typically administered before bedtime
  • Dose Range: 100–300 mcg per dose
  • Use Pattern: Often used in short cycles or as needed for sleep support
  • Dosing Protocol

Suggested approach for the 5 mg vial format.

  • Start: 100 mcg before bedtime to assess response
  • Target: 200–300 mcg nightly if needed
  • Frequency: Once daily (evening / pre-sleep)
  • Vial Duration: One 5 mg vial lasts approximately 15–50 doses, depending on usage
  • Timing: 30–60 minutes before sleep for best alignment with circadian rhythm
  • Mechanism of Action

DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide that is believed to interact with central nervous system pathways involved in sleep regulation and neuroendocrine function. It has been studied for its potential influence on hypothalamic signaling, stress hormone modulation, and circadian rhythm balance.

Research suggests DSIP may help modulate neurotransmitters associated with relaxation and sleep onset, potentially supporting deeper and more restorative sleep phases. It may also influence cortisol regulation, which can indirectly affect sleep quality and recovery.

  • Potential Benefits & Side Effects

Observations based on preclinical and limited human research.

Potential Benefits:

  • May support deeper and more restorative sleep
  • May reduce stress-related sleep disruption
  • May improve relaxation and sleep onset time
  • Potential support for recovery through improved sleep quality

Possible Side Effects:

  • Mild drowsiness or grogginess in some users
  • Occasional headache or vivid dreams
  • Injection-site irritation (if administered subcutaneously)
  • Human clinical data are limited; it remains investigational